Comparative evaluation of cost-effectiveness of alpha blockers prescribed in patients with non-neurogenic lower urinary tract symptoms due to benign prostatic hyperplasia

Conclusion: Tamsulosin was the most cost-effective drug among the prescribed alpha-blockers. Since all the prescribed alpha-blockers had comparable efficacy so we concluded that the most cost-effective drug should be preferred for long-duration treatment. [5] Alpha1-Blockers act symptomatically by reducing both storage and voiding LUTS in most of the cases, however, they have to be taken for a longer duration. [...]for such a long duration treatment, the cost of medication has a very important role. The remaining patients were assessed by IPSS chart and compliance rate of more than 80% was ensured. [...]78 patients completed the study. [...]the average cost of the treatment of widely prescribed alpha-blockers during the study was INR 1,233.12 for Tamsulosin, INR 2142 for Silodosin, and INR 1386 for Alfuzosin [Table 1].